Lv51
1203 积分 2022-10-08 加入
Influence of vedolizumab on extraintestinal manifestations in inflammatory bowel disease: a nationwide multicenter study of the GETECCU ENEIDA Registry
4天前
已关闭
Ustekinumab for ileal stricturing Crohn’s disease—an international multicenter retrospective cohort study
10天前
已完结
Ustekinumab for ileal stricturing Crohn’s disease—an international multicenter retrospective cohort study
11天前
已关闭
Ustekinumab for ileal stricturing Crohn’s disease—an international multicenter retrospective cohort study
11天前
已关闭
Ustekinumab for ileal stricturing Crohn’s disease—an international multicenter retrospective cohort study
11天前
已关闭
Ustekinumab therapy for moderately to severely active pediatric Crohn’s disease: UNITI Jr study safety and efficacy results in patients weighing at least 40 kg
14天前
已关闭
Ustekinumab therapy for moderately to severely active pediatric Crohn’s disease: UNITI Jr study safety and efficacy results in patients weighing at least 40 kg
14天前
已关闭
Distinct hepcidin patterns in Crohn’s disease and ulcerative colitis: links to iron homeostasis and inflammatory activity
14天前
已完结
Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study
17天前
已完结
Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study
17天前
已完结
皖公网安备34019202002308
